Search PubMed⌕ Search

PubMed · 15700339

Functional studies.

Abstract

For the first time, functional studies with ultrasound have been made possible by the introduction of microbubble contrast agents. That they are confined to the circulation and that the small volume boluses that are effective are particular advantages when compared to iodinated and gadolinium-based agents. Classical indicator dilution calculations can be applied to the transit curves that can be measured as the contrast washes into and out of a region of interest. In addition, it is sometimes possible to measure the transit of the bolus through the supply artery and the draining vein, e.g. of a kidney and thus calculate the true transit time. Similar timing measurements have proved particularly useful for measuring the portosystemic shunts that are a feature of liver metastases and cirrhosis. A unique feature of microbubble contrast agents is their fragility when insonated at higher (but still permissible) powers. This can be used to create a negative bolus and the reperfusion of a slice of tissue can then be followed. From the exponential refill curve, features that relate to true tissue perfusion can be extracted.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Adrian Lim, David Cosgrove. 2004. Functional studies.. https://doi.org/10.1007/s10406-004-0086-1

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Type, severity, frequency and management of adverse reactions associated with ultrasound contrast agents: a systematic review and meta-analysis.

OBJECTIVES: This systematic review and meta-analysis are aimed at evaluating the incidence of adverse drug reactions (ADRs) following administration of clinically approved ultrasound contrast agents (UCAs) in adults and children, to assess risks in patients with cardiovascular disease and in pregnancy, and to evaluate the effectiveness of emergency management of severe ADRs. MATERIALS AND METHODS: A PRISMA 2020 systematic review was conducted searching PubMed, Scopus, and Embase. Two reviewers independently screened, extracted data, and assessed quality. Incidence estimates were pooled when feasible, stratified by age group, contrast agent, and administration route. RESULTS: Seventy-four studies encompassing >&#x2009;1 million adults and >&#x2009;36,000 children were included, contributing multiple analytic cohorts to the quantitative synthesis. Severe acute ADRs were extremely rare (6 and 16 cases per 100,000 in adults and children, respectively) and absent following endocavitary administration in children. Non-severe acute ADRs occurred in 11 and 8 cases per 10,000 adults and children, respectively. Delayed reactions were very rare (<&#x2009;1 case per million in adults). No significant safety differences emerged between UCA products. The incidence of ADRs in patients with cardiovascular disease was analogous to the general population. No ADRs were reported in pregnant women. Standard emergency management was effective in almost all serious cases, though rare fatalities occurred. CONCLUSION: UCAs show an excellent safety profile in adults and children, with very rare severe ADRs and few non-severe, typically self-limiting reactions. Strict adherence to recommended emergency management protocols mitigates the remaining risks, supporting safe use across a broad range of clinical indications. PROSPERO REGISTRATION: CRD42023432668. KEY POINTS: Question What is the incidence, type, and severity of acute and delayed ADRs associated with clinically approved UCAs across different patient populations? Findings Severe acute adverse reactions are very rare, and non-severe reactions are rare and self-limiting, with no significant safety differences between adults, children, or patients with cardiovascular disease. Clinical relevant UCAs show an excellent safety profile across populations. These findings support their safe clinical use as reliable alternatives to iodine-based and gadolinium-based contrast agents in routine diagnostic imaging.

Contrast Media↗

Sonographic diagnosis of a saccular aneurysm of the internal jugular vein.

Aneurysm of the internal jugular vein is an extremely rare condition. It is usually detected during childhood and is characterized by being more prominent during Valsalva maneuvers such as vomiting, coughing, and straining. Most of the cases reported in the English literature are fusiform aneurysms of the internal jugular vein. We report the case of a saccular aneurysm of the left internal jugular vein in a 59-year-old woman with no change in size of the aneurysm during a Valsalva manuever.

Contrast Media↗

Standardize and compare contrast-enhanced ultrasonographic digital images obtained with different technologies: how to overcome the subjectivity.

OBJECTIVE: This study was conducted to compare digital images obtained with cadence contrast pulse sequencing (CPS) and coherent contrast imaging (CCI) technologies for contrast-enhanced ultrasonography (CEUS). METHODS: A CEUS study on 17 focal liver lesions was performed using CPS and CCI technologies with a second-generation contrast media. The lesion/liver ratio and conspicuity index were then calculated and compared with Adobe Photoshop 6.0. RESULTS: Lesion/liver ratio and conspicuity index using CCI ranged from 1.3 to 7.1 (mean value, 3) and 19 to 127 (mean value, 58), respectively; by using CPS, we obtained results ranging from 2 to 19.1 (mean value, 8.9) and 57 to 164 (mean value, 109.2). Lesion/liver ratio and the conspicuity index for the lesions using CPS showed significantly (p < 0.0001) superior results than those obtained using CCI. CONCLUSION: The computed analysis with standardization allows an objective evaluation of digital images of CEUS. CPS technology resulted in better lesion conspicuity compared to CCI during CEUS study on focal liver lesions.

Contrast Media↗